how to glp 1 medications work GLP-1 Infographic GLP-1 Medications for Weight Loss:

In April 2024, the Federal Trade Commission announced that it was expanding its campaign against pharmaceutical manufacturers improper or inaccurate listing of patents in the Food and Drug Administrations (FDA) Orange Book, disputing junk patent listings for diabetes, weight loss, asthma, and COPD drugs, including Novo Nordisk Inc.s blockbuster weight-loss drug, Ozempic. If the administration revoked Novos extension, patent protection for semaglutide will expire in 2026 as it is scheduled to do in many other countries

Research published in Cell Reports Medicine in 2026 concluded directly: weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function

For those taking insulin or sulfonylureas, this may increase hypoglycaemia risk, requiring medication review

This long-term catalyst can get lost in the justifiable enthusiasm over the companys GLP-1 drugs

Because of this, nutrition and strength training are important during treatment.Increasing protein intake can be important for maximizing fat loss while preserving muscle tissue when taking GLP-1 medications

The media frenzy over these so-called "weight loss drugs" has also resulted in pharmaceutical companies tightening restrictions on who is able to access the medications, leading to rejections of valid prescriptions, delays in treatment, and other issues